Kiniksa Pharmaceuticals Ownership 2024 | Who Owns Kiniksa Pharmaceuticals Now?
Institutional Ownership
0.00%
Insider Ownership
4.23%
Retail Ownership
95.77%
Institutional Holders
2.00
Kiniksa Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BARCLAYS PLC | 0.05% | 0.00% | 34,839 | -7,308 | -17.34% | 650,000 | Jun 30, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.04% | 0.52% | 30,000 | - | - | 560,100 | Jun 30, 2024 |
| ADIRONDACK TRUST CO | 0.00% | 0.01% | 875 | - | - | 16,266 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 623 | 523 | 523.00% | 11,631 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 451 | 311 | 222.14% | 8,000 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -15,664 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -22,185 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -116 | -100.00% | - | Jun 30, 2024 |
| M&T BANK CORP | - | - | - | -36,334 | -100.00% | - | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | - | - | - | -64,031 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -212,505 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -12,559 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -290,644 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -1,888,544 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -2,981,894 | -100.00% | - | Jun 30, 2024 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | - | - | - | -172,740 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -2,331 | -100.00% | - | Jun 30, 2024 |
| SEI INVESTMENTS CO | - | - | - | -73,481 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -506,299 | -100.00% | - | Jun 30, 2024 |
Kiniksa Pharmaceuticals's largest institutional shareholder is BARCLAYS PLC, holding 0.05% of the company's total share outstanding, currently valued at $650.00K. The top 10 institutional shareholders own together 0.09% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BIRCHVIEW CAPITAL, LP | 0.04% | 0.52% | 30,000 | - | - | 560,100 | Jun 30, 2024 |
| ADIRONDACK TRUST CO | 0.00% | 0.01% | 875 | - | - | 16,266 | Jun 30, 2024 |
| BARCLAYS PLC | 0.05% | 0.00% | 34,839 | -7,308 | -17.34% | 650,000 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 451 | 311 | 222.14% | 8,000 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 623 | 523 | 523.00% | 11,631 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -15,664 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -22,185 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -116 | -100.00% | - | Jun 30, 2024 |
| M&T BANK CORP | - | - | - | -36,334 | -100.00% | - | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | - | - | - | -64,031 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -212,505 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -12,559 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -290,644 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -1,888,544 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -2,981,894 | -100.00% | - | Jun 30, 2024 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | - | - | - | -172,740 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -2,331 | -100.00% | - | Jun 30, 2024 |
| SEI INVESTMENTS CO | - | - | - | -73,481 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -506,299 | -100.00% | - | Jun 30, 2024 |
The largest Kiniksa Pharmaceuticals shareholder by % of total assets is BIRCHVIEW CAPITAL, LP. The company owns 30.00K shares of Kiniksa Pharmaceuticals (KNSA), representing 0.52% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 623 | 523 | 523.00% | 11,631 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 451 | 311 | 222.14% | 8,000 | Jun 30, 2024 |
| ADIRONDACK TRUST CO | 0.00% | 0.01% | 875 | - | - | 16,266 | Jun 30, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.04% | 0.52% | 30,000 | - | - | 560,100 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -8 | -100.00% | - | Jun 30, 2024 |
| RIGGS ASSET MANAGMENT CO. INC. | - | - | - | -30 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -34 | -100.00% | - | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | - | - | - | -58 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -116 | -100.00% | - | Jun 30, 2024 |
| DAIWA SECURITIES GROUP INC. | - | - | - | -139 | -100.00% | - | Jun 30, 2024 |
| FORTITUDE FAMILY OFFICE, LLC | - | - | - | -249 | -100.00% | - | Jun 30, 2024 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -447 | -100.00% | - | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -500 | -100.00% | - | Jun 30, 2024 |
| PARALLEL ADVISORS, LLC | - | - | - | -518 | -100.00% | - | Jun 30, 2024 |
| CARMICHAEL HILL & ASSOCIATES, INC. | - | - | - | -532 | -100.00% | - | Jun 30, 2024 |
| LINDBROOK CAPITAL, LLC | - | - | - | -660 | -100.00% | - | Jun 30, 2024 |
| PACER ADVISORS, INC. | - | - | - | -660 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -758 | -100.00% | - | Jun 30, 2024 |
| GAMMA INVESTING LLC | - | - | - | -854 | -100.00% | - | Jun 30, 2024 |
| SIGNATUREFD, LLC | - | - | - | -943 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Kiniksa Pharmaceuticals's largest institutional buyer is ADVISOR GROUP HOLDINGS, INC.. The company purchased 523.00 stocks of KNSA, valued at $11.63K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | - | - | - | -4,193,907 | -100.00% | - | Jun 30, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | - | - | - | -3,204,841 | -100.00% | - | Jun 30, 2024 |
| HHLR ADVISORS, LTD. | - | - | - | -3,135,735 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -2,981,894 | -100.00% | - | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | - | - | - | -2,809,577 | -100.00% | - | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | - | - | - | -2,196,009 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -1,888,544 | -100.00% | - | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | - | - | - | -1,460,633 | -100.00% | - | Jun 30, 2024 |
| BRAIDWELL LP | - | - | - | -1,392,716 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -1,270,613 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -831,099 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -760,107 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -725,511 | -100.00% | - | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | - | - | - | -666,976 | -100.00% | - | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | - | - | - | -648,087 | -100.00% | - | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | - | - | - | -646,163 | -100.00% | - | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | - | - | - | -622,540 | -100.00% | - | Jun 30, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | - | - | - | -618,798 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -506,299 | -100.00% | - | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -500,000 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Kiniksa Pharmaceuticals's biggest institutional seller is BLACKROCK INC.. The company sold -4.19M shares of KNSA, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | - | - | - | -4,193,907 | -100.00% | - | Jun 30, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | - | - | - | -3,204,841 | -100.00% | - | Jun 30, 2024 |
| HHLR ADVISORS, LTD. | - | - | - | -3,135,735 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | - | - | - | -2,981,894 | -100.00% | - | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | - | - | - | -2,809,577 | -100.00% | - | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | - | - | - | -2,196,009 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -1,888,544 | -100.00% | - | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | - | - | - | -1,460,633 | -100.00% | - | Jun 30, 2024 |
| BRAIDWELL LP | - | - | - | -1,392,716 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -1,270,613 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -831,099 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -760,107 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -725,511 | -100.00% | - | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | - | - | - | -666,976 | -100.00% | - | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | - | - | - | -648,087 | -100.00% | - | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | - | - | - | -646,163 | -100.00% | - | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | - | - | - | -622,540 | -100.00% | - | Jun 30, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | - | - | - | -618,798 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -506,299 | -100.00% | - | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -500,000 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | - | - | - | -290,644 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -261,698 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -239,409 | -100.00% | - | Jun 30, 2024 |
| PEREGRINE CAPITAL MANAGEMENT LLC | - | - | - | -236,045 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -221,853 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -216,908 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -212,505 | -100.00% | - | Jun 30, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | - | - | - | -185,813 | -100.00% | - | Jun 30, 2024 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | - | - | - | -172,740 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -164,568 | -100.00% | - | Jun 30, 2024 |
| KNIGHTS OF COLUMBUS ASSET ADVISORS LLC | - | - | - | -162,283 | -100.00% | - | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | - | - | - | -159,323 | -100.00% | - | Jun 30, 2024 |
| HUSSMAN STRATEGIC ADVISORS, INC. | - | - | - | -157,500 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -156,210 | -100.00% | - | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -151,000 | -100.00% | - | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | - | - | - | -140,863 | -100.00% | - | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | - | - | - | -139,850 | -100.00% | - | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -137,647 | -100.00% | - | Jun 30, 2024 |
| LION POINT CAPITAL, LP | - | - | - | -130,691 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -128,821 | -100.00% | - | Jun 30, 2024 |
| NORDEA INVESTMENT MANAGEMENT AB | - | - | - | -126,742 | -100.00% | - | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | - | - | - | -124,878 | -100.00% | - | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | - | - | - | -117,231 | -100.00% | - | Jun 30, 2024 |
| LINDEN THOMAS ADVISORY SERVICES, LLC | - | - | - | -116,381 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -112,580 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -104,762 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -102,997 | -100.00% | - | Jun 30, 2024 |
| UBS OCONNOR LLC | - | - | - | -94,495 | -100.00% | - | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | - | - | - | -91,744 | -100.00% | - | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | - | - | - | -88,688 | -100.00% | - | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | - | - | - | -84,493 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -84,155 | -100.00% | - | Jun 30, 2024 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | - | - | - | -75,483 | -100.00% | - | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -73,906 | -100.00% | - | Jun 30, 2024 |
| SEI INVESTMENTS CO | - | - | - | -73,481 | -100.00% | - | Jun 30, 2024 |
| DARK FOREST CAPITAL MANAGEMENT LP | - | - | - | -70,596 | -100.00% | - | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | - | - | - | -66,918 | -100.00% | - | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | - | - | - | -64,031 | -100.00% | - | Jun 30, 2024 |
| RHUMBLINE ADVISERS | - | - | - | -61,431 | -100.00% | - | Jun 30, 2024 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | - | - | - | -61,106 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -59,954 | -100.00% | - | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -59,700 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -58,991 | -100.00% | - | Jun 30, 2024 |
| SWISS NATIONAL BANK | - | - | - | -55,600 | -100.00% | - | Jun 30, 2024 |
| JACKSON CREEK INVESTMENT ADVISORS LLC | - | - | - | -54,384 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | - | - | - | -54,320 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -50,078 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -46,060 | -100.00% | - | Jun 30, 2024 |
| MARTINGALE ASSET MANAGEMENT L P | - | - | - | -45,377 | -100.00% | - | Jun 30, 2024 |
| TEJARA CAPITAL LTD | - | - | - | -42,649 | -100.00% | - | Jun 30, 2024 |
| CAPULA MANAGEMENT LTD | - | - | - | -41,242 | -100.00% | - | Jun 30, 2024 |
| OPTIONS SOLUTIONS, LLC | - | - | - | -40,205 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -39,771 | -100.00% | - | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | - | - | - | -39,560 | -100.00% | - | Jun 30, 2024 |
| M&T BANK CORP | - | - | - | -36,334 | -100.00% | - | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | - | - | - | -34,062 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| CERITY PARTNERS LLC | - | - | - | -29,683 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -28,662 | -100.00% | - | Jun 30, 2024 |
| ALPS ADVISORS INC | - | - | - | -28,203 | -100.00% | - | Jun 30, 2024 |
| STRS OHIO | - | - | - | -28,100 | -100.00% | - | Jun 30, 2024 |
| JANNEY MONTGOMERY SCOTT LLC | - | - | - | -26,843 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -26,200 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -25,995 | -100.00% | - | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -22,557 | -100.00% | - | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | - | - | - | -22,347 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -22,185 | -100.00% | - | Jun 30, 2024 |
| PROFUND ADVISORS LLC | - | - | - | -22,026 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -21,912 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -20,935 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -19,160 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -17,856 | -100.00% | - | Jun 30, 2024 |
| MERCER GLOBAL ADVISORS INC /ADV | - | - | - | -17,689 | -100.00% | - | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | - | - | - | -17,349 | -100.00% | - | Jun 30, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | - | - | - | -17,141 | -100.00% | - | Jun 30, 2024 |
| VESTCOR INC | - | - | - | -17,000 | -100.00% | - | Jun 30, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -16,356 | -100.00% | - | Jun 30, 2024 |
| ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. | - | - | - | -15,982 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -15,664 | -100.00% | - | Jun 30, 2024 |
| QRG CAPITAL MANAGEMENT, INC. | - | - | - | -15,178 | -100.00% | - | Jun 30, 2024 |
Kiniksa Pharmaceuticals's largest sold out institutional shareholder by shares sold is BLACKROCK INC., sold -4.19M shares, valued at -, as of undefined.
Kiniksa Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| WANGER ADVISORS TRUST | 0.50% | 272,453 | - | - | Mar 31, 2024 |
| COLUMBIA ACORN TRUST | 0.34% | 1,098,682 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 21,265 | - | - | Mar 31, 2024 |
| FORUM FUNDS II | 0.01% | 14,034 | 858 | 6.51% | Mar 31, 2024 |
| Humankind Benefit Corp | 0.01% | 248 | - | - | Dec 31, 2023 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 79,516 | -495 | -0.62% | Mar 28, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,632,759 | -453,501 | -14.69% | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 47,116 | - | - | Mar 28, 2024 |
| ALPS ETF Trust | 0.00% | 43,040 | -25,965 | -37.63% | Feb 29, 2024 |
| Destra Investment Trust | 0.00% | 5,507 | 391 | 7.64% | Mar 31, 2024 |
| JAMES ADVANTAGE FUNDS | 0.00% | 6,909 | - | - | Dec 31, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 706 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.00% | 36,699 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 7,642 | -251 | -3.18% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 186,740 | - | - | Jan 31, 2024 |
| Nushares ETF Trust | 0.00% | 14,683 | - | - | Jan 31, 2024 |
| TIMOTHY PLAN | 0.00% | 7,991 | 1,071 | 15.48% | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 43,640 | - | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 22,257 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 17,844 | - | - | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 40,976 | -16,853 | -29.14% | Feb 29, 2024 |
| ProFunds | 0.00% | 7,397 | 1,760 | 31.22% | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 18,485 | -1,456 | -7.30% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 92,039 | -17,202 | -15.75% | Jan 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 18,747 | -294 | -1.54% | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 27,696 | - | - | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 44,566 | 10,879 | 32.29% | Feb 29, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 14,105 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 96,981 | 4,544 | 4.92% | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 96,431 | 2,106 | 2.23% | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 407,486 | 396,165 | 3499.38% | Mar 31, 2024 |
| Global X Funds | 0.00% | 15,634 | - | - | Jan 31, 2024 |
| North Square Investments Trust | 0.00% | 3,366 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 110,913 | 81,213 | 273.44% | Jan 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 4,367 | - | - | Dec 31, 2023 |
| GPS Funds I | 0.00% | 1,118 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 21,729 | 2,213 | 11.34% | Feb 29, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 41,731 | 30,954 | 287.22% | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 26,583 | -3,740 | -12.33% | Mar 28, 2024 |
| NEW COVENANT FUNDS | 0.00% | 801 | - | - | Dec 31, 2023 |
| ALLSPRING MASTER TRUST | 0.00% | 9,508 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 389,911 | - | - | Jan 31, 2024 |
| Meeder Funds | 0.00% | 496 | - | - | Mar 31, 2024 |
| Victory Portfolios II | 0.00% | 3,973 | 937 | 30.86% | Mar 31, 2024 |
| Columbia Funds Series Trust II | 0.00% | 25,964 | - | - | Jan 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 137,400 | 13,950 | 11.30% | Feb 29, 2024 |
| THRIVENT MUTUAL FUNDS | 0.00% | 6,122 | - | - | Mar 28, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 21,700 | 9,353 | 75.75% | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 141,651 | -90,335 | -38.94% | Dec 31, 2023 |
| THRIVENT SERIES FUND INC | 0.00% | 3,209 | - | - | Mar 28, 2024 |
| PGIM ETF TRUST | 0.00% | 1,914 | - | - | Feb 29, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 8,535 | 5 | 0.06% | Dec 31, 2023 |
| MUTUAL FUND SERIES TRUST | 0.00% | 110,000 | - | - | Mar 31, 2024 |
| EMPOWER FUNDS, INC. | 0.00% | 23,957 | 23,957 | - | Mar 31, 2024 |
| ALLSPRING FUNDS TRUST | 0.00% | 8,438 | - | - | Jan 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 442 | - | - | Mar 31, 2024 |
| Pacer Funds Trust | 0.00% | 524 | -373 | -41.58% | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,073 | - | - | Feb 29, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 514 | - | - | Dec 31, 2023 |
| ETF Series Solutions | 0.00% | 183 | - | - | Jan 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 126,554 | 42,359 | 50.31% | Feb 29, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 27,381 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 11,869 | -500 | -4.04% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 943 | 330 | 53.83% | Feb 29, 2024 |
| Bridge Builder Trust | 0.00% | 13,147 | -338 | -2.51% | Mar 31, 2024 |
| Investment Managers Series Trust | 0.00% | 3,175 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 2,269 | - | - | Dec 31, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 102 | 18 | 21.43% | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 3,912 | -771 | -16.46% | Jan 31, 2024 |
| John Hancock Funds II | 0.00% | 3,468 | - | - | Feb 29, 2024 |
Kiniksa Pharmaceuticals's largest mutual fund holder by % of total assets is "WANGER ADVISORS TRUST", owning 272.45K shares, compromising 0.50% of its total assets.
Kiniksa Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 2 | -98.75% |
| 31 Mar, 24 | 160 | 6.67% |
| 31 Dec, 23 | 150 | 3.45% |
| 30 Sep, 23 | 145 | 6.62% |
| 30 Jun, 23 | 136 | -2.16% |
| 31 Mar, 23 | 139 | 2.96% |
| 31 Dec, 22 | 135 | 17.39% |
| 30 Sep, 22 | 115 | 18.56% |
| 30 Jun, 22 | 97 | -5.83% |
| 31 Mar, 22 | 103 | -6.36% |
| 31 Dec, 21 | 110 | 0.92% |
| 30 Sep, 21 | 109 | -6.03% |
| 30 Jun, 21 | 116 | -1.69% |
| 31 Mar, 21 | 118 | 1.72% |
| 31 Dec, 20 | 116 | 4.50% |
| 30 Sep, 20 | 111 | 14.43% |
| 30 Jun, 20 | 97 | 27.63% |
| 31 Mar, 20 | 76 | 24.59% |
| 31 Dec, 19 | 61 | 15.09% |
| 30 Sep, 19 | 53 | -14.52% |
| 30 Jun, 19 | 62 | 10.71% |
| 31 Mar, 19 | 56 | 7.69% |
| 31 Dec, 18 | 52 | -3.70% |
| 30 Sep, 18 | 54 | 31.71% |
| 30 Jun, 18 | 41 | - |
As of 30 Jun 24, 2 institutions are holding Kiniksa Pharmaceuticals's shares, representing a decrease of -98.75% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 1,326 | -100.00% |
| 31 Mar, 24 | 38,944,112 | 13.77% |
| 31 Dec, 23 | 34,231,785 | -1.90% |
| 30 Sep, 23 | 34,893,836 | 9.74% |
| 30 Jun, 23 | 31,796,147 | -0.05% |
| 31 Mar, 23 | 31,813,005 | 5.03% |
| 31 Dec, 22 | 30,289,236 | 1.23% |
| 30 Sep, 22 | 29,920,261 | -0.02% |
| 30 Jun, 22 | 29,927,684 | -2.77% |
| 31 Mar, 22 | 30,780,585 | 4.58% |
| 31 Dec, 21 | 29,433,958 | 1.00% |
| 30 Sep, 21 | 29,141,326 | 0.94% |
| 30 Jun, 21 | 28,869,066 | -0.62% |
| 31 Mar, 21 | 29,048,421 | -2.43% |
| 31 Dec, 20 | 29,771,536 | 3.76% |
| 30 Sep, 20 | 28,693,148 | 35.75% |
| 30 Jun, 20 | 21,136,794 | 19.49% |
| 31 Mar, 20 | 17,688,966 | 17.04% |
| 31 Dec, 19 | 15,113,844 | -2.72% |
| 30 Sep, 19 | 15,536,525 | -6.28% |
| 30 Jun, 19 | 16,577,520 | 1.57% |
| 31 Mar, 19 | 16,320,893 | 18.97% |
| 31 Dec, 18 | 13,718,366 | -4.87% |
| 30 Sep, 18 | 14,420,957 | -16.46% |
| 30 Jun, 18 | 17,262,299 | - |
Kiniksa Pharmaceuticals (KNSA) has 1.33K shares outstanding as of 30 Jun 24, down -100.00% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 0.00% | - |
| 31 Mar, 24 | 55.34% | 2.33% |
| 31 Dec, 23 | 48.77% | 1.96% |
| 30 Sep, 23 | 49.91% | 2.40% |
| 30 Jun, 23 | 45.58% | 2.19% |
| 31 Mar, 23 | 45.61% | 2.41% |
| 31 Dec, 22 | 43.51% | 2.34% |
| 30 Sep, 22 | 43.08% | 2.31% |
| 30 Jun, 22 | 43.19% | 2.18% |
| 31 Mar, 22 | 44.52% | 2.42% |
| 31 Dec, 21 | 42.92% | 2.38% |
| 30 Sep, 21 | 42.44% | 2.38% |
| 30 Jun, 21 | 42.21% | 2.33% |
| 31 Mar, 21 | 42.55% | 2.22% |
| 31 Dec, 20 | 43.74% | 2.31% |
| 30 Sep, 20 | 43.50% | 3.27% |
| 30 Jun, 20 | 36.50% | 3.57% |
| 31 Mar, 20 | 31.97% | 4.09% |
| 31 Dec, 19 | 27.96% | 3.48% |
| 30 Sep, 19 | 28.34% | 3.06% |
| 30 Jun, 19 | 30.43% | 3.06% |
| 31 Mar, 19 | 31.53% | 3.93% |
| 31 Dec, 18 | 28.31% | 3.20% |
| 30 Sep, 18 | 29.76% | 0.43% |
| 30 Jun, 18 | 83.04% | - |
As of 30 Jun 24, Kiniksa Pharmaceuticals is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 1 | -98.82% |
| 31 Mar, 24 | 85 | 23.19% |
| 31 Dec, 23 | 69 | - |
| 30 Sep, 23 | 69 | 1.47% |
| 30 Jun, 23 | 68 | -13.92% |
| 31 Mar, 23 | 79 | 9.72% |
| 31 Dec, 22 | 72 | 18.03% |
| 30 Sep, 22 | 61 | 38.64% |
| 30 Jun, 22 | 44 | -8.33% |
| 31 Mar, 22 | 48 | -22.58% |
| 31 Dec, 21 | 62 | 10.71% |
| 30 Sep, 21 | 56 | 5.66% |
| 30 Jun, 21 | 53 | 6.00% |
| 31 Mar, 21 | 50 | -20.63% |
| 31 Dec, 20 | 63 | -16.00% |
| 30 Sep, 20 | 75 | 2.74% |
| 30 Jun, 20 | 73 | 65.91% |
| 31 Mar, 20 | 44 | 7.32% |
| 31 Dec, 19 | 41 | 51.85% |
| 30 Sep, 19 | 27 | -30.77% |
| 30 Jun, 19 | 39 | -2.50% |
| 31 Mar, 19 | 40 | 60.00% |
| 31 Dec, 18 | 25 | -32.43% |
| 30 Sep, 18 | 37 | -9.76% |
| 30 Jun, 18 | 41 | - |
1 institutional shareholders have increased their position in KNSA stock as of 30 Jun 24 compared to 85 in the previous quarter (a -98.82% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | - | -100.00% |
| 31 Mar, 24 | 48 | -14.29% |
| 31 Dec, 23 | 56 | 24.44% |
| 30 Sep, 23 | 45 | 4.65% |
| 30 Jun, 23 | 43 | 26.47% |
| 31 Mar, 23 | 34 | -5.56% |
| 31 Dec, 22 | 36 | 24.14% |
| 30 Sep, 22 | 29 | 11.54% |
| 30 Jun, 22 | 26 | -13.33% |
| 31 Mar, 22 | 30 | 11.11% |
| 31 Dec, 21 | 27 | - |
| 30 Sep, 21 | 27 | -12.90% |
| 30 Jun, 21 | 31 | -22.50% |
| 31 Mar, 21 | 40 | 48.15% |
| 31 Dec, 20 | 27 | 58.82% |
| 30 Sep, 20 | 17 | 21.43% |
| 30 Jun, 20 | 14 | -41.67% |
| 31 Mar, 20 | 24 | 100.00% |
| 31 Dec, 19 | 12 | -20.00% |
| 30 Sep, 19 | 15 | 7.14% |
| 30 Jun, 19 | 14 | 180.00% |
| 31 Mar, 19 | 5 | -66.67% |
| 31 Dec, 18 | 15 | 50.00% |
| 30 Sep, 18 | 10 | - |
| 30 Jun, 18 | - | - |
- institutional shareholders have reduced their position in KNSA stock as of 30 Jun 24 compared to 48 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 2 | -98.75% | 1,326 | -100.00% | 0.00% | - | 1 | -98.82% | - | -100.00% |
| 31 Mar, 24 | 160 | 6.67% | 38,944,112 | 13.77% | 55.34% | 2.33% | 85 | 23.19% | 48 | -14.29% |
| 31 Dec, 23 | 150 | 3.45% | 34,231,785 | -1.90% | 48.77% | 1.96% | 69 | - | 56 | 24.44% |
| 30 Sep, 23 | 145 | 6.62% | 34,893,836 | 9.74% | 49.91% | 2.40% | 69 | 1.47% | 45 | 4.65% |
| 30 Jun, 23 | 136 | -2.16% | 31,796,147 | -0.05% | 45.58% | 2.19% | 68 | -13.92% | 43 | 26.47% |
| 31 Mar, 23 | 139 | 2.96% | 31,813,005 | 5.03% | 45.61% | 2.41% | 79 | 9.72% | 34 | -5.56% |
| 31 Dec, 22 | 135 | 17.39% | 30,289,236 | 1.23% | 43.51% | 2.34% | 72 | 18.03% | 36 | 24.14% |
| 30 Sep, 22 | 115 | 18.56% | 29,920,261 | -0.02% | 43.08% | 2.31% | 61 | 38.64% | 29 | 11.54% |
| 30 Jun, 22 | 97 | -5.83% | 29,927,684 | -2.77% | 43.19% | 2.18% | 44 | -8.33% | 26 | -13.33% |
| 31 Mar, 22 | 103 | -6.36% | 30,780,585 | 4.58% | 44.52% | 2.42% | 48 | -22.58% | 30 | 11.11% |
| 31 Dec, 21 | 110 | 0.92% | 29,433,958 | 1.00% | 42.92% | 2.38% | 62 | 10.71% | 27 | - |
| 30 Sep, 21 | 109 | -6.03% | 29,141,326 | 0.94% | 42.44% | 2.38% | 56 | 5.66% | 27 | -12.90% |
| 30 Jun, 21 | 116 | -1.69% | 28,869,066 | -0.62% | 42.21% | 2.33% | 53 | 6.00% | 31 | -22.50% |
| 31 Mar, 21 | 118 | 1.72% | 29,048,421 | -2.43% | 42.55% | 2.22% | 50 | -20.63% | 40 | 48.15% |
| 31 Dec, 20 | 116 | 4.50% | 29,771,536 | 3.76% | 43.74% | 2.31% | 63 | -16.00% | 27 | 58.82% |
| 30 Sep, 20 | 111 | 14.43% | 28,693,148 | 35.75% | 43.50% | 3.27% | 75 | 2.74% | 17 | 21.43% |
| 30 Jun, 20 | 97 | 27.63% | 21,136,794 | 19.49% | 36.50% | 3.57% | 73 | 65.91% | 14 | -41.67% |
| 31 Mar, 20 | 76 | 24.59% | 17,688,966 | 17.04% | 31.97% | 4.09% | 44 | 7.32% | 24 | 100.00% |
| 31 Dec, 19 | 61 | 15.09% | 15,113,844 | -2.72% | 27.96% | 3.48% | 41 | 51.85% | 12 | -20.00% |
| 30 Sep, 19 | 53 | -14.52% | 15,536,525 | -6.28% | 28.34% | 3.06% | 27 | -30.77% | 15 | 7.14% |
| 30 Jun, 19 | 62 | 10.71% | 16,577,520 | 1.57% | 30.43% | 3.06% | 39 | -2.50% | 14 | 180.00% |
| 31 Mar, 19 | 56 | 7.69% | 16,320,893 | 18.97% | 31.53% | 3.93% | 40 | 60.00% | 5 | -66.67% |
| 31 Dec, 18 | 52 | -3.70% | 13,718,366 | -4.87% | 28.31% | 3.20% | 25 | -32.43% | 15 | 50.00% |
| 30 Sep, 18 | 54 | 31.71% | 14,420,957 | -16.46% | 29.76% | 0.43% | 37 | -9.76% | 10 | - |
| 30 Jun, 18 | 41 | - | 17,262,299 | - | 83.04% | - | 41 | - | - | - |
Kiniksa Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Kiniksa Pharmaceuticals's stock was made by Patel Sanj K on Jul 25 2024, selling 136,124 shares at $1.59 per share (valued at $216.44K).
Kiniksa Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 3 | 11 | 27.27% |
| Q2 2024 | 54 | 32 | 168.75% |
| Q1 2024 | 9 | 19 | 47.37% |
| Q4 2023 | 5 | 10 | 50.00% |
| Q3 2023 | 28 | 30 | 93.33% |
| Q2 2023 | 47 | 13 | 361.54% |
| Q1 2023 | 14 | 24 | 58.33% |
| Q4 2022 | 3 | 6 | 50.00% |
| Q3 2022 | 14 | 12 | 116.67% |
| Q2 2022 | 25 | 2 | 1250.00% |
| Q1 2022 | 12 | 23 | 52.17% |
| Q4 2021 | 1 | - | - |
| Q3 2021 | 17 | - | - |
| Q2 2021 | 9 | 24 | 37.50% |
| Q1 2021 | 24 | 11 | 218.18% |
| Q4 2020 | 5 | 17 | 29.41% |
| Q3 2020 | 9 | 2 | 450.00% |
| Q2 2020 | 11 | 7 | 157.14% |
| Q1 2020 | 10 | 16 | 62.50% |
| Q4 2019 | 4 | 2 | 200.00% |
3 total buy trades, and 11 total sell trades (buy/sell ratio of 0.27%) were made by Kiniksa Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 8 | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | 11 | - |
| Q4 2023 | - | 5 | - |
| Q3 2023 | - | 4 | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | 2 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | 7 | - |
| Q4 2020 | - | 4 | - |
| Q3 2020 | - | 2 | - |
| Q2 2020 | - | 5 | - |
| Q1 2020 | - | 7 | - |
| Q4 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 8 open market sell trades of Kiniksa Pharmaceuticals's stocks.
Kiniksa Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| GRCL | Gracell Biotechnologies Inc. |
| NUVL | Nuvalent, Inc. |
| GOSS | Gossamer Bio, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| LRMR | Larimar Therapeutics, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| PHAT | Phathom Pharmaceuticals, Inc. |
| VTYX | Ventyx Biosciences, Inc. |
| CERE | Cerevel Therapeutics Holdings, Inc. |
| COGT | Cogent Biosciences, Inc. |
| SPRO | Spero Therapeutics, Inc. |
| REPL | Replimune Group, Inc. |
| KRON | Kronos Bio, Inc. |
| BOLT | Bolt Biotherapeutics, Inc. |
| ACLX | Arcellx, Inc. |
| GPCR | Structure Therapeutics Inc. |
| NLTX | Neurogene Inc. |
| KURA | Kura Oncology, Inc. |
| CHRS | Coherus BioSciences, Inc. |
| KRTX | Karuna Therapeutics, Inc. |
| LYRA | Lyra Therapeutics, Inc. |
| NVCT | Nuvectis Pharma, Inc. |
KNSA Ownership FAQ
Who Owns Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals is owned by institutional shareholders (0.00%), insiders (4.23%), and public (95.77%). The largest institutional shareholder of Kiniksa Pharmaceuticals is BARCLAYS PLC (0.05% of total shares) and the top mutual fund owner is WANGER ADVISORS TRUST (0.50% of total shares).
Who are the major institutional shareholders of Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals's major institutional shareholders are BARCLAYS PLC, BIRCHVIEW CAPITAL, LP, ADIRONDACK TRUST CO, ADVISOR GROUP HOLDINGS, INC., and CWM, LLC. The top five shareholders own together 0.09% of the company's share outstanding.
How many Kiniksa Pharmaceuticals shareholders are there?
As of Jun 2024, there are 2 institutional shareholders of Kiniksa Pharmaceuticals.
What percentage of Kiniksa Pharmaceuticals is owned by BARCLAYS PLC?
BARCLAYS PLC owns 34.84K shares of Kiniksa Pharmaceuticals, representing 0.05% of the company's total shares outstanding, valued at $650K (as of Jun 2024).
What percentage of Kiniksa Pharmaceuticals is owned by BIRCHVIEW CAPITAL, LP?
As of Jun 2024, BIRCHVIEW CAPITAL, LP holds 30K shares of Kiniksa Pharmaceuticals (KNSA), compromising 0.04% of the company, valued at $560.1K.
What percentage of Kiniksa Pharmaceuticals is owned by ADIRONDACK TRUST CO?
ADIRONDACK TRUST CO is the third largest holder of Kiniksa Pharmaceuticals. The company owns 875 of the company's shares outstanding (worth $16.27K).